Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs NIO Inc. (NIO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs NIO Inc. — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.03 (market cap $3.94B), while NIO Inc. trades at $3.39 (market cap $8.54B). The key difference: NIO Inc. is far larger — about 2.2× Edgewise Therapeutics Inc. Common Stock's market cap, and Edgewise Therapeutics Inc. Common Stock is trading nearer its 52-week high, NIO Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and NIO Inc. for 81 Days on average.
| EWTX | NIO | |
|---|---|---|
Market Cap | $3.94B | $8.54B |
Volume | 810,104 | 34,684,903 |
Sector | Health | Consumer Cyclical |
52-Week High | $48.35 | $7.42 |
52-Week Low | $14.89 | $3.37 |
Typical Hold Time | 0 Days | 81 Days |
Enterprise Value | $3.48B | $6.43B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NIO trades at $3.41, down 1.73% on the day and near its 52-week low, reflecting a bearish technical trend. The company reported a net loss of $15.57 billion in 2025, though revenue grew to $87.49 billion and the net loss margin improved to -17.8%. Recent news highlights a strategic battery-swapping partnership with Geely, which could expand NIO's network but has weighed on the stock as investors assess profitability ahead of Q3 2026 earnings.
The outlook remains challenging due to persistent losses and intense EV competition, but analyst consensus is a Buy with a $6.23 price target, suggesting significant upside. Key risks include high debt, cash burn, and price wars in China's EV market, while opportunities lie in scaling the battery-swap network and potential margin improvement if delivery growth continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About NIO Inc.
NIO Inc. manufactures and sells automobiles. The Company offers electric vehicles and parts, as well as provides battery charging services. NIO serves customers worldwide.
Read more on NIO →
